Phuong Khanh Morrow serves as Executive at CRISPR Therapeutics AG, where they oversee executive responsibilities. Since joining the company, Phuong Khanh Morrow has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on May 24, 2023 involved selling 2,527 shares valued at $166.6K.
Phuong Khanh Morrow currently holds 4,411 shares of CRISPR Therapeutics AG (CRSP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Phuong Khanh Morrow has been a net neutral trader of CRSP stock. They have purchased $0 and sold $0 worth of shares.
Phuong Khanh Morrow's most recent insider trade was on May 24, 2023, when they sold 2,527 shares at $65.91 per share.
Get notified when new Form 4 filings are submitted
| 6,938 |
| $N/A |
| Discretionary |